Filing Details

Accession Number:
0001144204-11-069089
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-12-09 09:41:15
Reporting Period:
2011-12-08
Filing Date:
2011-12-09
Accepted Time:
2011-12-09 09:41:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
811641 Immucell Corp ICCC In Vitro & In Vivo Diagnostic Substances (2835) 010382980
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1136546 H Joseph Crabb C/O Immucell Corporation
56 Evergreen Drive
Portland ME US 04103
Vice President And Cso Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-12-08 1,000 $3.20 114,111 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Options Disposition 2011-12-08 1,000 $0.00 1,000 $3.20
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2004-12-12 2011-12-10 No 4 X Direct